At this time, posts about UbioLogics are rapidly increasing on portals and stock communities, with foreign investors tentatively recorded as net buying 50,444 shares today. UbioLogics is known as a company engaged in the research and development of biological preparations and pharmaceuticals.
As of 1:30 PM on the 22nd, UbioLogics' stock price is 21,550 KRW, down 4.86% from the previous day, with a trading volume of 1,457,801 shares, which is about 58.76% of the 5-day average trading volume. On January 21, UbioLogics became a market issue with the headline "Decline despite COVID-19 vaccine clinical approval."
In addition to UbioLogics, posts by investors are also surging for Global SM (900070), Wonik IPS (240810), and WISCOM (024070).

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
